概述

  • 产品名称Anti-AP1+2 beta抗体
  • 描述
    兔多克隆抗体to AP1+2 beta
  • 特异性Based on sequence analysis, this antibody will bind the beta subunit of both the AP-1 and AP-2 complexes.
  • 经测试应用适用于: WB, IHC-Fr, IHC-Pmore details
  • 种属反应性
    与反应: Mouse, Rat, Human
  • 免疫原

    Synthetic peptide:

    KKGEIFELKAELNSDKKEK

    , corresponding to N terminal amino acids 10-29 of AP1 and 2 (beta).

  • 阳性对照
    • Rat brain lysate

性能

  • 形式Liquid
  • 存放说明Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • 存储溶液Preservative: 0.01% Thimerosal (merthiolate)
    Constituents: Whole serum
  • 纯度Whole antiserum
  • 纯化说明0.2ml filtered lyophilized serum.
  • 克隆多克隆
  • 同种型IgG
  • 研究领域

应用

Our Abpromise guarantee covers the use of ab21981 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB
IHC-Fr
IHC-P
  • 应用说明IHC-Fr: 1/500 - 1/5000. depending on tissue and
    detection method.
    IHC-P: 1/500 - 1/5000. depending on tissue and
    detection method.
    WB: 1/2000 - 1/10000. depending on detection method. Predicted molecular weight: 100 kDa.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • 靶标

    Anti-AP1+2 beta antibody (ab21981)参考文献

    This product has been referenced in:
    • Poulsen ET  et al. An Aberrant Phosphorylation of Amyloid Precursor Protein Tyrosine Regulates Its Trafficking and the Binding to the Clathrin Endocytic Complex in Neural Stem Cells of Alzheimer's Disease Patients. Front Mol Neurosci 10:59 (2017). IP . Read more (PubMed: 28360834) »

    See 1 Publication for this product

    Product Wall

    Abcam guarantees this product to work in the species/application used in this Abreview.
    Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
    Sample Rat Tissue sections (kidney)
    Specification kidney
    Antigen retrieval step Heat mediated
    Blocking step Serum as blocking agent for 4 hour(s) and 0 minute(s) · Concentration: 3%
    Username

    Dr. Immaculada Herrero-Fresneda

    Verified customer

    提交于 Jan 05 2006

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"